Scandinavian Chemotech Ab Stock Current Valuation
| CMOTEC-B | SEK 1.74 0.04 2.35% |
Valuation analysis of Scandinavian ChemoTech helps investors to measure Scandinavian ChemoTech's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Scandinavian ChemoTech's price fluctuation is dangerous at this time. Calculation of the real value of Scandinavian ChemoTech is based on 3 months time horizon. Increasing Scandinavian ChemoTech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Scandinavian ChemoTech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Scandinavian Stock. However, Scandinavian ChemoTech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.74 | Real 1.58 | Hype 1.74 | Naive 1.77 |
The real value of Scandinavian Stock, also known as its intrinsic value, is the underlying worth of Scandinavian ChemoTech Company, which is reflected in its stock price. It is based on Scandinavian ChemoTech's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Scandinavian ChemoTech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Scandinavian ChemoTech AB helps investors to forecast how Scandinavian stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Scandinavian ChemoTech more accurately as focusing exclusively on Scandinavian ChemoTech's fundamentals will not take into account other important factors: Scandinavian ChemoTech AB Company Current Valuation Analysis
Scandinavian ChemoTech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Scandinavian ChemoTech Current Valuation | 68.38 M |
Most of Scandinavian ChemoTech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Scandinavian ChemoTech AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Scandinavian ChemoTech AB has a Current Valuation of 68.38 M. This is 99.52% lower than that of the Healthcare sector and 98.53% lower than that of the Biotechnology industry. The current valuation for all Sweden stocks is 99.59% higher than that of the company.
Scandinavian Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Scandinavian ChemoTech's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Scandinavian ChemoTech could also be used in its relative valuation, which is a method of valuing Scandinavian ChemoTech by comparing valuation metrics of similar companies.Scandinavian ChemoTech is currently under evaluation in current valuation category among its peers.
Scandinavian Fundamentals
| Return On Equity | -1.17 | |||
| Return On Asset | -0.51 | |||
| Operating Margin | (48.69) % | |||
| Current Valuation | 68.38 M | |||
| Shares Outstanding | 10.64 M | |||
| Shares Owned By Insiders | 26.03 % | |||
| Shares Owned By Institutions | 3.32 % | |||
| Price To Book | 8.87 X | |||
| Price To Sales | 159.69 X | |||
| Revenue | 49 K | |||
| Gross Profit | 2.86 M | |||
| EBITDA | (20.02 M) | |||
| Net Income | (17.74 M) | |||
| Cash And Equivalents | 5.62 M | |||
| Cash Per Share | 1.65 X | |||
| Total Debt | 53 K | |||
| Debt To Equity | 2.10 % | |||
| Current Ratio | 7.09 X | |||
| Book Value Per Share | 0.79 X | |||
| Cash Flow From Operations | (19.18 M) | |||
| Earnings Per Share | (2.19) X | |||
| Beta | 1.56 | |||
| Market Capitalization | 113.35 M | |||
| Total Asset | 25.81 M | |||
| Net Asset | 25.81 M |
About Scandinavian ChemoTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Scandinavian ChemoTech AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scandinavian ChemoTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scandinavian ChemoTech AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Scandinavian Stock
Scandinavian ChemoTech financial ratios help investors to determine whether Scandinavian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Scandinavian with respect to the benefits of owning Scandinavian ChemoTech security.